CA: A Cancer Journal for Clinicians, Vol 24, 339-347, Copyright
© 1974 by American Cancer Society
Ovarian Cancer
Hugh R. K. Barber M.D.1,
Edward A. Graber M.D.2, and
Tae Hae Kwon M.D.3
1 Director, Department of Obstetrics and Gynecology, Lenox Hill Hospital, New York, New York; Attending Surgeon, Gynecologic Service, Memorial Hospital for Cancer and Allied Diseases; Attending Obstetrician-Gynecologist, New York Hospital; and Clinical Professor of Obstetrics and Gynecology, Cornell Medical College, New York.
2 Associate Director, Department of Obstetrics and Gynecology, Lenox Hill Hospital and Clinical Associate Professor of Obstetrics and Gynecology, Cornell Medical College, New York.
3 Fellow in Gynecologic Oncology (New York City Division, American Cancer Society), Lenox Hill Hospital, New York.
Early diagnosis is the most effective means of reducing the currently high mortality rate associated with ovarian cancer. The palpation of what appears to be a normal sized ovary in a premenopausal woman suggests an ovarian tumor in a postmenopausal woman. Also, rule out ovarian cancer in any 40-60 year old woman who presents with persistent, unexplained GI symptoms. Ninety percent of all ovarian tumors are of epithelial origin. Treatment consists of total hysterectomy, bilateral salpingo-oophorectomy, omentectomy, appendectomy and instillation of P32. In Stage II through IV cancers, post-operative irradiation is added to the protocol.